{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T08:30:48Z","timestamp":1769848248767,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1124\/dmd.105.004721","type":"journal-article","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T00:33:18Z","timestamp":1114129998000},"page":"892-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4"],"prefix":"10.1016","volume":"33","author":[{"given":"Antonius E.","family":"van Herwaarden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan W.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf W.","family":"Sparidans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Wagenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia M.M.","family":"van der Kruijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan H.M.","family":"Schellens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred H.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.105.004721_bib1","first-page":"4416","article-title":"Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.","volume":"6","author":"Bardelmeijer","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.105.004721_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mcp.2003.10","article-title":"Coordinate induction of both cytochrome P4503A and MDR1 by St John\u2019s wort in healthy subjects.","volume":"73","author":"Dresser","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.105.004721_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200038010-00003","article-title":"Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.","volume":"38","author":"Dresser","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.105.004721_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-4347(98)00137-6","article-title":"Sensitive assay for midazolam and its metabolite 1\u2032-hydroxymidazolam in human plasma by capillary high-performance liquid chromatography.","volume":"710","author":"Eeckhoudt","year":"1998","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1124\/dmd.105.004721_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1124\/dmd.31.5.548","article-title":"Expression of the human CYP3A4 gene in small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam.","volume":"31","author":"Granvil","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.105.004721_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P450 3A4: regulation and role in drug metabolism.","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.105.004721_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5414\/CPP42139","article-title":"Drug interactions with St. John\u2019s wort (Hypericum perforatum): a review of the clinical evidence.","volume":"42","author":"Izzo","year":"2004","journal-title":"Int J Pharmacol Ther"},{"key":"10.1124\/dmd.105.004721_bib8","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/dmd.30.10.1108","article-title":"Interindividual variability and tissue-specificity in the expression of cytochrome P450 mRNA.","volume":"30","author":"Koch","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.105.004721_bib9","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1093\/nar\/19.15.4293","article-title":"Simplified mammalian DNA isolation procedure.","volume":"19","author":"Laird","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.105.004721_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0169-409X(02)00066-2","article-title":"Genetic contribution to variable human CYP3A-mediated metabolism.","volume":"54","author":"Lamba","year":"2002","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1124\/dmd.105.004721_bib11","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1081\/JLC-100106096","article-title":"Performance of the analytical assays of paclitaxel, docetaxel and cyclosporin in a routine hospital laboratory.","volume":"24","author":"Malingr\u00e9","year":"2001","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"10.1124\/dmd.105.004721_bib12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1006\/bbrc.1996.0493","article-title":"Immuno-localization of H+\/peptide cotransporter in rat digestive tract.","volume":"220","author":"Ogihara","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.105.004721_bib13","first-page":"234","article-title":"The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors.","volume":"1619","author":"Pascussi","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.105.004721_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(99)05467-7","article-title":"Acute heart transplant rejection due to Saint John\u2019s wort.","volume":"355","author":"Ruschitzka","year":"2000","journal-title":"Lancet"},{"key":"10.1124\/dmd.105.004721_bib15","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1016\/S0021-9258(18)53085-4","article-title":"A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice.","volume":"268","author":"Simonet","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.105.004721_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-3565(25)22834-8","article-title":"Use of midazolam as a human cytochrome P450 3A probe. I. In vitro-in vivo correlations in liver transplant patients.","volume":"271","author":"Thummel","year":"1994","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624032033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624032033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.105.004721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:09:41Z","timestamp":1739898581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624032033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0090955624032033"],"URL":"https:\/\/doi.org\/10.1124\/dmd.105.004721","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.105.004721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}